Heilongjiang, China

Jing Gao

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Harbin Pharmaceutical Group Co., Ltd. General Pharmaceutical Factory. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jing Gao. Retrieved from https://idiyas.com/inventor/jing-gao-7b3q22wb

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank


Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Jing Gao

Introduction

Jing Gao is a notable inventor based in Heilongjiang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that can aid in the treatment of serious medical conditions.

Latest Patents

Jing Gao holds a patent for "Salts and crystal forms of diaza-benzofluoranthrene compounds." This invention discloses various salts, including hydrochloride, citrate, phosphate, and sulfate salts of compound 1. The patent also details the crystal forms of these salts and their preparation methods. Furthermore, it relates to their use in the preparation of a medicament for treating cerebral apoplexy or epilepsy. He has 1 patent to his name.

Career Highlights

Jing Gao is associated with Harbin Pharmaceutical Group Co., Ltd., specifically the General Pharmaceutical Factory. His work in this organization has allowed him to focus on innovative pharmaceutical solutions that address critical health issues.

Collaborations

Some of his notable coworkers include Qingqing Lu and Shenyi Shi, who contribute to the collaborative efforts in research and development within the company.

Conclusion

Jing Gao's work exemplifies the impact of innovation in the pharmaceutical industry. His contributions are vital for advancing medical treatments and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…